---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-296174"
form_type: "8-K"
ticker: "ACHV"
cik: "0000949858"
company_name: "ACHIEVE LIFE SCIENCES, INC."
filed_at: "2026-07-06T20:06:28+00:00"
generated_at: "2026-07-06T20:07:04.118862+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Achieve Life Sciences shareholders approve doubling authorized common shares to 300M

## Summary
- Shareholders approved Certificate of Amendment increasing authorized common shares from 150M to 300M.
- All nine director nominees elected, including Jeffrey Farrow, Andrew Goldberg, and others.
- Ratification of PricewaterhouseCoopers LLP as independent auditor for FY 2026 approved.
- Non-binding advisory vote on named executive officer compensation passed with 46.4M for, 0.6M against.
- Certificate of Amendment filed with Delaware Secretary of State on July 6, 2026.

## SEC filing metadata
- accession: 0001193125-26-296174
- form_type: 8-K
- ticker: ACHV
- cik: 0000949858
- company_name: ACHIEVE LIFE SCIENCES, INC.
- filed_at: 2026-07-06T20:06:28+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.03, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/949858/000119312526296174/0001193125-26-296174-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/949858/000119312526296174/achv-20260702.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-296174
- JSON: https://secwatch.observer/filing/0001193125-26-296174.json
- Plain text: https://secwatch.observer/filing/0001193125-26-296174.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.